Submit an outstanding young person in the drug and alcohol testing industry In 2025, NDASA will recognize 30 incredible young professionals in our industry aged 30 and under who represent the future of safe workplaces, families and communities. Submissions meeting the...
Jonathan Baktari, MD, CEO, US Drug Test Centers Research tells us that approximately 3.8% of the world’s population (or 158.8 million people) uses marijuana. In 2023, about 17% of Americans reported smoking marijuana, which was higher than in previous years. And —...
By Jonathan Baktari, MD, CEO of US Drug Test Centers Are your employees sober while they’re on the clock? Concerning statistics suggest that more professionals are testing positive for illicit drugs while simultaneously, fewer companies are conducting...
By William J. Judge, JD, LL.M., and Nick Hartman, Drug Screening Compliance Institute Background It has been estimated that as many as 45 million workplace drug tests are conducted each year in the United States. The most recent Quest Diagnostics Drug Testing Index...
By Rob Schiller, CEO, Impairment Science, Inc., developer of the DRUID® fitness-for-duty app It might seem nonsensical to equate the evaluation of an employee’s fitness for on-the-job duty with the evaluation of a professional baseball player’s ability – but it’s not....
By Premier Biotech This information is provided for educational purposes only. Reader retains full responsibility for the use of the information contained herein. Over the past several years, some employers have made the misguided decision to cut back on their drug...
Make your voice heard! You can have an impact on the U.S. Drug Enforcement Administration’s proposal to reschedule marijuana from a Schedule I drug to a Schedule III drug under the Controlled Substances Act by providing comment to the NPRM. The deadline for submitting...
Reprinted article courtesy of Quest Diagnostics, a leading provider of diagnostic information services. Key Findings The overall drug positivity held steady at historically high rates in 2023, while marijuana positivity continued an upward climb in the general U.S....
By Keith Graves, President Graves and Associates This article is reprinted with permission from the Drug Intelligence Bulletin With the dynamic nature of the novel psychoactive substances (NPS) market, forensic toxicology laboratories face the ongoing challenge of...
By Samantha M. Simons MsEd, CEO and Founder of Gillon Diagnostics & Associates “Integrity is doing the right thing even when no one is watching.” C.S. LewisSubstance abuse is proven to harm people’s lives and their respective careers. More than 60% of adults who...